Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
05/29/2009
Trade Name:
Lamictal XR
Generic or Proper Name (*):
lamotrigine
Indications Studied:
Adjunctive therapy for partial onset seizures in patients e13 years of age
Therapeutic Category:
Anticonvulsant
Ages Studied:
13 years and older
Study #:
1
Study Type:
Efficacy/Safety/Pharmacokinetic/Tolerability
Study Design:
Single-Blind/Placebo/Parallel Group/Population Pharmacokinetic
No Patients:
9
No Centers:
154
No Countries:
9
BPCA(B), PREA(P):
P
-
-